DuPont Fabros Technology, Inc. Announces Participation in Upcoming Investor Conference
31 oct. 2016 16h05 HE | DuPont Fabros Technology, Inc.
WASHINGTON, Oct. 31, 2016 (GLOBE NEWSWIRE) -- DuPont Fabros Technology Inc. (NYSE:DFT), a leading, owner, developer, operator and manager of enterprise-class, carrier-neutral, large multi-tenant...
BEI_ONC_4C_FlatLogo_Horizontal.jpg
BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences
31 août 2016 16h15 HE | BeiGene, LTD.
WALTHAM, Mass., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology...
Exa Corporation to Present at the Canaccord Genuity Growth Conference
04 août 2016 08h30 HE | Exa Corporation
BURLINGTON, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Exa® Corporation (NASDAQ:EXA), a global innovator in simulation software for product engineering, today announced that its Chief Executive...
Exa Corporation to Present at Upcoming Investor Conferences
31 mai 2016 16h05 HE | Exa Corporation
BURLINGTON, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Exa® Corporation (NASDAQ:EXA), a leading innovator of simulation software for product engineering, today announced that its management is...
forward logo.jpg
Forward Pharma CFO to Participate in Two Investor Conferences in February
09 févr. 2016 09h22 HE | Forward Pharma A/S
COPENHAGEN, Denmark, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl...
PGNX Logo (Vector)-FFF.png
Progenics Pharmaceuticals to Present at Upcoming Investor Conferences
01 févr. 2016 08h45 HE | Progenics Pharmaceuticals Inc.
TARRYTOWN, N.Y., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company focused on developing innovative ways to target and treat cancer, announced...
Caladrius_Logo_March_2017.png
Caladrius Biosciences Announces Presentations at Upcoming Investor Conferences in February
28 janv. 2016 07h30 HE | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Jan. 28, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
emergent logo.jpg
Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook, and Outlines New Five-Year (2016-2020) Strategic Growth Plan
11 janv. 2016 07h01 HE | Emergent Biosolutions, Inc.
2015 Preliminary Estimates:Total revenues of $520 to $525 million, a 16% increase over 2014 (at midpoint)GAAP net income of $60 to $64 million, a 69% increase over 2014 (at midpoint)Adjusted net...
emergent logo.jpg
Emergent BioSolutions to Participate in First Quarter 2016 Investor Conferences
21 déc. 2015 16h15 HE | Emergent Biosolutions, Inc.
GAITHERSBURG, Md., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the following...
Pernix Therapeutics, Inc. logo
Pernix Therapeutics to Host Meetings at Upcoming Conferences
10 nov. 2015 16h30 HE | Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...